v3.26.3
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Income Statement [Abstract]        
Collaboration revenue $ 0 $ 1,741 $ 3,381 $ 5,277
Type of Revenue [Extensible List] us-gaap:LicenseMember us-gaap:LicenseMember us-gaap:LicenseMember us-gaap:LicenseMember
Operating expenses:        
Research and development $ 24,215 $ 25,838 $ 73,305 $ 82,404
General and administrative 8,032 10,638 26,457 35,856
Total operating expenses 32,247 36,476 99,762 118,260
Loss from operations (32,247) (34,735) (96,381) (112,983)
Other income (expense):        
Interest income 1,409 2,575 4,831 8,832
Change in fair value of stock price appreciation milestones 151 (90) (509) 117
Other income 0 0 0 93
Total other income 1,560 2,485 4,322 9,042
Net loss (30,687) (32,250) (92,059) (103,941)
Other comprehensive loss:        
Unrealized gain (loss) on available-for-sale securities, net (38) 91 (271) (115)
Comprehensive loss $ (30,725) $ (32,159) $ (92,330) $ (104,056)
Net loss per common share, basic $ (0.25) $ (0.27) $ (0.76) $ (0.88)
Net loss per common share, diluted $ (0.25) $ (0.27) $ (0.76) $ (0.88)
Weighted-average common shares used to compute basic net loss per share 123,656,809 118,998,693 121,374,895 118,636,375
Weighted-average common shares used to compute diluted net loss per share 123,656,809 118,998,693 121,374,895 118,636,375